Pharmiva AB (publ)
PHARM SE0015530670
ICB 2010 : Health Care / Health CareSweden 223 81
SE-M Lund Scheelevägen 4
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-8% | -85% | -66% | 0% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 13 Insiders: 4
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Anna Linton CEO |
1.70 SEK |
17,500 Bought |
29,750 SEK |
03/01/2023 | 03/01/2023 |
Anna Linton CEO |
1.65 SEK |
4,646 Bought |
7,665 SEK |
03/01/2023 | 02/01/2023 |
Anna Linton CEO |
1.65 SEK |
18,940 Bought |
31,251 SEK |
22/12/2022 | 20/12/2022 |
Malte Zaunders CB |
9.97 SEK |
2,600 Bought |
25,922 SEK |
26/05/2021 | 25/05/2021 |
Malte Zaunders CB |
9.40 SEK |
191 Bought |
1,795 SEK |
26/05/2021 | 25/05/2021 |
Malte Zaunders CB |
9.50 SEK |
9,523 Bought |
90,469 SEK |
26/05/2021 | 25/05/2021 |
Malte Zaunders CB |
9.95 SEK |
500 Bought |
4,975 SEK |
26/05/2021 | 25/05/2021 |
Malte Zaunders CB |
9.78 SEK |
3,061 Bought |
29,937 SEK |
26/05/2021 | 25/05/2021 |
Malte Zaunders CB |
9.75 SEK |
1,818 Bought |
17,726 SEK |
26/05/2021 | 25/05/2021 |
Malte Zaunders CB |
9.65 SEK |
2,072 Bought |
19,995 SEK |
26/05/2021 | 25/05/2021 |